Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A by Sankaran Vijay G, Menne Tobias F, Xu Jian, Akie Thomas E, Lettre Guillaume, Van Handel Ben, Mikkola Hanna K A, Hirschhorn Joel N, Cantor Alan B, Orkin Stuart H in Science (New York, N.Y.) (2008).

[PMID: 19056937] PubMed


Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the beta-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the beta-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in beta-hemoglobin disorders.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.